San-Miguel, Jesús F.
Kantarjian, Hagop M.
Article History
First Online: 16 December 2014
Competing interests
: J.F.S.-M. has acted in a consultancy or advisory capacity for Bristol–Myers Squibb, Celgene, Janssen, Millennium, MSD, Novartis and Onyx. H.M.K. has received research grants from Amgen, ARIAD, Bristol–Myers Squibb, Novartis and Pfizer.